Fact CheckerSign in

NCT07188272Completed

Effect of High-intensity Interval Training Combined With DASH Diet on Arterial Stiffness in Hypertensive Patients

Effect of High-intensity Interval Training Combined With DASH Diet on Arterial Stiffness in Hypertensive Patients: a Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 3 Jun 2026

Brief summary (registry, in English)

Cardiovascular disease (CVD) is one of the leading causes of mortality worldwide and a major risk factor for morbidity worldwide . It is necessary to reduce the incidence and risk factors of CVD, as physical activity is known to reduce mortality from CVD. Arterial stiffness and hypertension are closely related in pathophysiology. Chronic high blood pressure (BP) can lead to arterial wall damage by mechanical stress, endothelial dysfunction, increased inflammation, oxidative stress, and renin-angiotensin-aldosterone system (RAAS) activation. HIIT has been shown to be equally or even better at stimulating health benefits than moderate-intensity continuous training (MICT) and is considered a time-saving aerobic exercise for reducing arterial stiffness in HTN patients

Status (registry)
Completed
Study type
Interventional
Enrollment
66 (actual)
First submitted
15 Sept 2025
Start date
10 Jul 2025
Primary completion date
10 Dec 2025
Lead sponsor
Deraya University
NCT number
NCT07188272

What you commit to

  • Study type: Interventional
  • Participants enrolled: 66
  • From 10 Jul 2025 to the primary completion date, 10 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Uncontrolled hypertension.
  • Unstable cardiac conditions
  • Severe pulmonary disease that limit exercise

Other

  • Severe HTN \<180/110 mmhg
  • Renal dysfunction
  • Impaired cognition
  • Musculoskeletal problems that made it difficult to do exercise

Who the study is looking for

  • Their age\< 35 up to 50 years old
  • Both sexes.
  • Controlled HTN ( stage 1,B.P 140-159 mmhg / 90-99 mmhg and stage 2, B.P 160-179 mmhg-100-109 mmhg )
  • Hemodynamic stable. Able to provide informed consent

Age in the registry: 35 years to 50 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Waleed Mohamed Abdelmohsen Abdelsalalm
Coordinator of this site? Confirm its status
MinyaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.